Donald Huffman

Donald Huffman

Geen lopende functies
79 jaar
Health Technology
Consumer Services
Finance

Profiel

Donald D.
Huffman
served as Chief Financial Officer at Celtrix Pharmaceuticals, Inc. from 1981 to 2000.
Held Chief Financial Officer roles at Sanderling Management CO LLC (2004-2006), Guava Technologies, Inc. (2006-2008), Asante Solutions, Inc. (2008-2010), and WaferGen Bio-systems, Inc. (2010-2012).
Occupied Chief Executive Officer & Chief Financial Officer positions at WaferGen Bio-systems, Inc. from 2010 to 2012.
Served as Director at Aerami Therapeutics, Inc. (2013-2014), SteadyMed Therapeutics, Inc. (2015-2018), and Aerami Therapeutics Holdings, Inc. Also held External Director role at SteadyMed Ltd. (2015-2018).
Chief Executive Officer & Director at Amarantus Bioscience Holdings, Inc. from 2021 to 2025.
Held Chief Financial Officer roles at Merck & Co., Inc., Essential Therapeutics, Inc., Philips Image Guided Therapy Corp., and Genteric, Inc. Education includes undergraduate degree from The Pennsylvania State University and MBA from State University of New York at Buffalo.

Eerdere bekende functies van Donald Huffman

BedrijvenFunctieEinde
AMARANTUS BIOSCIENCE HOLDINGS, INC. Algemeen Directeur 01-10-2025
STEADYMED LTD Directeur/Bestuurslid 30-08-2018
Directeur/Bestuurslid 01-01-2018
WAFERGEN BIO-SYSTEMS, INC. Financieel Directeur/CFO 26-03-2012
ASANTE SOLUTIONS INC Financieel Directeur/CFO 01-09-2010
Ervaring van Donald Huffman in detail bekijken

Opleiding van Donald Huffman

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

37

Eerstegraads connecties

16

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit16

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Donald Huffman